Transfusion Medicine Reviews
Volume 21, Issue 3 , Pages 223-236, July 2007

The Evidence for the Use of Recombinant Human Activated Factor VII in the Treatment of Bleeding Patients With Quantitative and Qualitative Platelet Disorders

  • Man-Chiu Poon

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Man-Chiu Poon, MD, University of Calgary, Foothills Hospital, 1403-29th St NW, Calgary, Alberta, Canada, T2N 2T9.

Department of Medicine, University of Calgary, Calgary, Alberta, Canada

Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada

Department of Oncology, University of Calgary, Calgary, Alberta, Canada

Southern Alberta Hemophilia Clinic, Calgary Health Region, Calgary, Alberta, Canada

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0887-7963(07)00019-3

doi:10.1016/j.tmrv.2007.03.003

Transfusion Medicine Reviews
Volume 21, Issue 3 , Pages 223-236, July 2007

Article Tools

* Image Usage & Resolution